Long-term Follow-up Study of Patients Who Received hLB-001 Gene Therapy

L

LogicBio Therapeutics

Status

Active, not recruiting

Conditions

Methylmalonic Acidemia

Treatments

Drug: hLB-001

Study type

Observational

Funder types

Industry

Identifiers

NCT05506254
LB-001LT

Details and patient eligibility

About

This is a non-interventional long-term follow-up study of patients who have participated in LogicBio studies for the treatment of MMA and received hLB-001

Full description

Patients will be followed for a period of 15 years which includes the duration of time that the patient was in the treatment study.

Enrollment

4 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

Participant has previously participated in a LogicBio clinical trial and received hLB-001.

Exclusion criteria

None

Trial design

4 participants in 1 patient group

Patients who have previously received hLB-001
Treatment:
Drug: hLB-001

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Research sites

Find research sitesLearn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy NoticeTerms
© Copyright 2024 Veeva Systems